150 related articles for article (PubMed ID: 36420423)
1. Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signature.
Priestley JRC; Pace LM; Sen K; Aggarwal A; Alves CAPF; Campbell IM; Cuddapah SR; Engelhardt NM; Eskandar M; Jolín García PC; Gropman A; Helbig I; Hong X; Gowda VK; Lusk L; Trapane P; Srinivasan VM; Suwannarat P; Ganetzky RD
Mol Genet Metab Rep; 2022 Dec; 33():100931. PubMed ID: 36420423
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell-derived hepatocytes reveal TCA cycle disruption and the potential basis for triheptanoin treatment for malate dehydrogenase 2 deficiency.
Mathis D; Koch J; Koller S; Sauter K; Flück C; Uldry AC; Forny P; Froese DS; Laemmle A
Mol Genet Metab Rep; 2024 Jun; 39():101066. PubMed ID: 38425868
[TBL] [Abstract][Full Text] [Related]
3. Triheptanoin - Novel therapeutic approach for the ultra-rare disease mitochondrial malate dehydrogenase deficiency.
Laemmle A; Steck AL; Schaller A; Kurth S; Perret Hoigné E; Felser AD; Slavova N; Salvisberg C; Atencio M; Mochel F; Nuoffer JM; Gautschi M
Mol Genet Metab Rep; 2021 Dec; 29():100814. PubMed ID: 34712577
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic RNA binding of the mitochondrial TCA cycle enzyme malate dehydrogenase.
Noble M; Chatterjee A; Sekaran T; Schwarzl T; Hentze MW
RNA; 2024 Jun; 30(7):839-853. PubMed ID: 38609156
[TBL] [Abstract][Full Text] [Related]
5. Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy.
Ait-El-Mkadem S; Dayem-Quere M; Gusic M; Chaussenot A; Bannwarth S; François B; Genin EC; Fragaki K; Volker-Touw CLM; Vasnier C; Serre V; van Gassen KLI; Lespinasse F; Richter S; Eisenhofer G; Rouzier C; Mochel F; De Saint-Martin A; Abi Warde MT; de Sain-van der Velde MGM; Jans JJM; Amiel J; Avsec Z; Mertes C; Haack TB; Strom T; Meitinger T; Bonnen PE; Taylor RW; Gagneur J; van Hasselt PM; Rötig A; Delahodde A; Prokisch H; Fuchs SA; Paquis-Flucklinger V
Am J Hum Genet; 2017 Jan; 100(1):151-159. PubMed ID: 27989324
[TBL] [Abstract][Full Text] [Related]
6. MDH1 deficiency is a metabolic disorder of the malate-aspartate shuttle associated with early onset severe encephalopathy.
Broeks MH; Shamseldin HE; Alhashem A; Hashem M; Abdulwahab F; Alshedi T; Alobaid I; Zwartkruis F; Westland D; Fuchs S; Verhoeven-Duif NM; Jans JJM; Alkuraya FS
Hum Genet; 2019 Dec; 138(11-12):1247-1257. PubMed ID: 31538237
[TBL] [Abstract][Full Text] [Related]
7. MDH2 produced OAA is a metabolic switch rewiring the fuelling of respiratory chain and TCA cycle.
Molinié T; Cougouilles E; David C; Cahoreau E; Portais JC; Mourier A
Biochim Biophys Acta Bioenerg; 2022 Mar; 1863(3):148532. PubMed ID: 35063410
[TBL] [Abstract][Full Text] [Related]
8. Structural Comparison of hMDH2 Complexed with Natural Substrates and Cofactors: The Importance of Phosphate Binding for Active Conformation and Catalysis.
Eo Y; Duong MTH; Ahn HC
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139014
[TBL] [Abstract][Full Text] [Related]
9. Inborn disorders of the malate aspartate shuttle.
Broeks MH; van Karnebeek CDM; Wanders RJA; Jans JJM; Verhoeven-Duif NM
J Inherit Metab Dis; 2021 Jul; 44(4):792-808. PubMed ID: 33990986
[TBL] [Abstract][Full Text] [Related]
10. Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia.
Jungtrakoon Thamtarana P; Marucci A; Pannone L; Bonnefond A; Pezzilli S; Biagini T; Buranasupkajorn P; Hastings T; Mendonca C; Marselli L; Di Paola R; Abubakar Z; Mercuri L; Alberico F; Flex E; Ceròn J; Porta-de-la-Riva M; Ludovico O; Carella M; Martinelli S; Marchetti P; Mazza T; Froguel P; Trischitta V; Doria A; Prudente S
J Clin Endocrinol Metab; 2022 Feb; 107(3):668-684. PubMed ID: 34718610
[TBL] [Abstract][Full Text] [Related]
11. Malate dehydrogenase of the cytosol. A kinetic investigation of the reaction mechanism and a comparison with lactate dehydrogenase.
Lodola A; Shore JD; Parker DM; Holbrook J
Biochem J; 1978 Dec; 175(3):987-98. PubMed ID: 217361
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a.
Shi Q; Gibson GE
J Neurochem; 2011 Aug; 118(3):440-8. PubMed ID: 21623795
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cytosolic malate dehydrogenase (MDH2) causes overproduction of specific organic acids in Saccharomyces cerevisiae.
Pines O; Shemesh S; Battat E; Goldberg I
Appl Microbiol Biotechnol; 1997 Aug; 48(2):248-55. PubMed ID: 9299784
[TBL] [Abstract][Full Text] [Related]
14. Phylogenetics and biochemistry elucidate the evolutionary link between l-malate and l-lactate dehydrogenases and disclose an intermediate group of sequences with mix functional properties.
Brochier-Armanet C; Madern D
Biochimie; 2021 Dec; 191():140-153. PubMed ID: 34418486
[TBL] [Abstract][Full Text] [Related]
15. Validation of a yeast malate dehydrogenase 2 (Mdh2) antibody tested for use in western blots.
Gabay-Maskit S; Schuldiner M; Zalckvar E
F1000Res; 2018; 7():130. PubMed ID: 29568493
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of cytosolic and mitochondrial malate dehydrogenases isolated from domestic cats (Felis catus).
Sasaki N; Nakamura M; Soeta S
Genet Mol Res; 2014 Aug; 13(3):6855-64. PubMed ID: 25177965
[TBL] [Abstract][Full Text] [Related]
17. Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure.
Wilkins HM; Koppel S; Carl SM; Ramanujan S; Weidling I; Michaelis ML; Michaelis EK; Swerdlow RH
J Neurochem; 2016 Apr; 137(1):76-87. PubMed ID: 26811028
[TBL] [Abstract][Full Text] [Related]
18. Functions of the membrane-associated and cytoplasmic malate dehydrogenases in the citric acid cycle of Corynebacterium glutamicum.
Molenaar D; van der Rest ME; Drysch A; Yücel R
J Bacteriol; 2000 Dec; 182(24):6884-91. PubMed ID: 11092846
[TBL] [Abstract][Full Text] [Related]
19. Malate valves: old shuttles with new perspectives.
Selinski J; Scheibe R
Plant Biol (Stuttg); 2019 Jan; 21 Suppl 1(Suppl Suppl 1):21-30. PubMed ID: 29933514
[TBL] [Abstract][Full Text] [Related]
20. Bi-allelic variants in MDH2: Expanding the clinical phenotype.
Ticci C; Nesti C; Rubegni A; Doccini S; Baldacci J; Dal Canto F; Ragni L; Cordelli DM; Donati MA; Santorelli FM
Clin Genet; 2022 Feb; 101(2):260-264. PubMed ID: 34766628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
